{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:05:39Z","timestamp":1787987139551,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,9]]},"DOI":"10.7759\/cureus.33559","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:18:00Z","timestamp":1673309880000},"source":"Crossref","is-referenced-by-count":2,"title":["Valproate-Induced Encephalopathy Presenting at Therapeutic Blood Concentrations: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Gautham","family":"Pavar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinan","family":"Sawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vichar","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Valproic Acid","author":"Rahman M","year":"2022","unstructured":"Rahman M, Nguyen H. Valproic Acid. StatPearls. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou J","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998, 279:1200-5. 10.1001\/jama.279.15.1200","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13092","article-title":"Toxic alcohol ingestion: a case report and review of management pathways","volume":"13","author":"Atluri P","year":"2021","unstructured":"Atluri P, Vasireddy D, Malayala SV. Toxic alcohol ingestion: a case report and review of management pathways. Cureus. 2021, 13:e13092. 10.7759\/cureus.13092","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/15563659209038632","article-title":"Cerebral edema following acute sodium valproate overdose","volume":"30","author":"Khoo SH","year":"1992","unstructured":"Khoo SH, Leyland MJ. Cerebral edema following acute sodium valproate overdose. J Toxicol Clin Toxicol. 1992, 30:209-14. 10.3109\/15563659209038632","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06289-0","article-title":"Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey","volume":"240","author":"Hosseini H","year":"2023","unstructured":"Hosseini H, Shafie M, Shakiba A, Ghayyem H, Mayeli M, Hassani M, Aghamollaii V. Valproic acid-induced hyperammonemia in neuropsychiatric disorders: a 2-year clinical survey. Psychopharmacology (Berl). 2023, 240:149-56. 10.1007\/s00213-022-06289-0","journal-title":"Psychopharmacology (Berl)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw ML","year":"2014","unstructured":"Batshaw ML, Tuchman M, Summar M, Seminara J. A longitudinal study of urea cycle disorders. Mol Genet Metab. 2014, 113:127-30. 10.1016\/j.ymgme.2014.08.001","journal-title":"Mol Genet Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18040363","article-title":"Fulminant onset of valproate-associated hyperammonemic encephalopathy","volume":"176","author":"Baumgartner J","year":"2019","unstructured":"Baumgartner J, Hoeflich A, Hinterbuchinger B, et al.. Fulminant onset of valproate-associated hyperammonemic encephalopathy. Am J Psychiatry. 2019, 176:900-3. 10.1176\/appi.ajp.2019.18040363","journal-title":"Am J Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2362679","article-title":"A case of carbamazepine-induced aggravation of self-limited epilepsy with centrotemporal spikes epilepsy and valproate-induced hyperammonemic encephalopathy in a child with heterozygous gene variant of carbomoyl phosphatase synthetase deficiency","volume":"2021","author":"Kankananarachchi I","year":"2021","unstructured":"Kankananarachchi I, Jasinge E, Hewawitharana G. A case of carbamazepine-induced aggravation of self-limited epilepsy with centrotemporal spikes epilepsy and valproate-induced hyperammonemic encephalopathy in a child with heterozygous gene variant of carbomoyl phosphatase synthetase deficiency. Case Rep Neurol Med. 2021, 2021:2362679. 10.1155\/2021\/2362679","journal-title":"Case Rep Neurol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux PE","year":"2009","unstructured":"Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol (Phila). 2009, 47:101-11. 10.1080\/15563650902752376","journal-title":"Clin Toxicol (Phila)"},{"key":"ref10","article-title":"The effect of carnitine supplementation on hyperammonemia and carnitine deficiency treated with valproic acid in a psychiatric setting","volume":"12","author":"Nakamura M","year":"2015","unstructured":"Nakamura M, Nagamine T. The effect of carnitine supplementation on hyperammonemia and carnitine deficiency treated with valproic acid in a psychiatric setting. Innov Clin Neurosci. 2015, 12:18-24.","journal-title":"Innov Clin Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108220","article-title":"Effects of L-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate","volume":"122","author":"Okumura A","year":"2021","unstructured":"Okumura A, Takagi M, Numoto S, Iwayama H, Azuma Y, Kurahashi H. Effects of L-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate. Epilepsy Behav. 2021, 122:108220. 10.1016\/j.yebeh.2021.108220","journal-title":"Epilepsy Behav"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-022-00984-z","article-title":"L-carnitine does not improve valproic acid poisoning management: a cohort study with toxicokinetics and concentration\/effect relationships","volume":"12","author":"Nguyen P","year":"2022","unstructured":"Nguyen P, Chevillard L, Gouda AS, et al.. L-carnitine does not improve valproic acid poisoning management: a cohort study with toxicokinetics and concentration\/effect relationships. Ann Intensive Care. 2022, 12:7. 10.1186\/s13613-022-00984-z","journal-title":"Ann Intensive Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/1735-1995.166211","article-title":"Favorable results after conservative management of 316 valproate intoxicated patients","volume":"20","author":"Shadnia S","year":"2015","unstructured":"Shadnia S, Amiri H, Hassanian-Moghaddam H, Rezai M, Vasei Z, Ghodrati N, Zamani N. Favorable results after conservative management of 316 valproate intoxicated patients. J Res Med Sci. 2015, 20:656-61. 10.4103\/1735-1995.166211","journal-title":"J Res Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.01.020","article-title":"Levocarnitine induced seizures in patients on valproic acid: a negative systematic review","volume":"36","author":"Zeiler FA","year":"2016","unstructured":"Zeiler FA, Sader N, Gillman LM, West M. Levocarnitine induced seizures in patients on valproic acid: a negative systematic review. Seizure. 2016, 36:36-9. 10.1016\/j.seizure.2016.01.020","journal-title":"Seizure"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12705","article-title":"Intentional use of carbapenem antibiotics for valproic acid toxicity: a case report","volume":"43","author":"Khobrani MA","year":"2018","unstructured":"Khobrani MA, Dudley SW, Huckleberry YC, et al.. Intentional use of carbapenem antibiotics for valproic acid toxicity: a case report. J Clin Pharm Ther. 2018, 43:723-5. 10.1111\/jcpt.12705","journal-title":"J Clin Pharm Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-240140","article-title":"Thinking out of the box: management of valproic acid toxicity with carbapenems","volume":"14","author":"Sanivarapu R","year":"2021","unstructured":"Sanivarapu R, Sharma R, Akella J. Thinking out of the box: management of valproic acid toxicity with carbapenems. BMJ Case Rep. 2021, 14:e240140. 10.1136\/bcr-2020-240140","journal-title":"BMJ Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767070-00006","article-title":"Comparative review of the carbapenems","volume":"67","author":"Zhanel GG","year":"2007","unstructured":"Zhanel GG, Wiebe R, Dilay L, et al.. Comparative review of the carbapenems. Drugs. 2007, 67:1027-52. 10.2165\/00003495-200767070-00006","journal-title":"Drugs"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku111","article-title":"The risk of seizures among the carbapenems: a meta-analysis","volume":"69","author":"Cannon JP","year":"2014","unstructured":"Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. The risk of seizures among the carbapenems: a meta-analysis. J Antimicrob Chemother. 2014, 69:2043-55. 10.1093\/jac\/dku111","journal-title":"J Antimicrob Chemother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.33588\/rn.6509.2017226","article-title":"Tratamiento de la encefalopat\u00eda por \u00e1cido valproico con \u00e1cido carbagl\u00famico: descripci\u00f3n de dos casos y revisi\u00f3n de la bibliograf\u00eda [Article in Spanish]","volume":"65","author":"Nava-Mateos JJ","year":"2017","unstructured":"Nava-Mateos JJ, Roiz-Rey P, Diaz Alvarez-Mediavilla J, Cebrian-Novella D, Gomez-Del Olmo V, Ceberio-Hualde L. Tratamiento de la encefalopat\u00eda por \u00e1cido valproico con \u00e1cido carbagl\u00famico: descripci\u00f3n de dos casos y revisi\u00f3n de la bibliograf\u00eda [Article in Spanish]. Rev Neurol. 2017, 65:409-14. 10.33588\/rn.6509.2017226","journal-title":"Rev Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3047329","article-title":"The role of renal replacement therapy in the management of pharmacologic poisonings","volume":"2016","author":"Mirrakhimov AE","year":"2016","unstructured":"Mirrakhimov AE, Barbaryan A, Gray A, Ayach T. The role of renal replacement therapy in the management of pharmacologic poisonings. Int J Nephrol. 2016, 2016:3047329. 10.1155\/2016\/3047329","journal-title":"Int J Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15968","article-title":"Rapid rescue from hyperammonemic coma after valproic acid poisoning: dual therapy with continuous renal replacement therapy and L-carnitine supplementation","volume":"13","author":"Gandam Venkata SK","year":"2021","unstructured":"Gandam Venkata SK, Guillotte K, Murphy B, Bhuram SS, Bhuram SC. Rapid rescue from hyperammonemic coma after valproic acid poisoning: dual therapy with continuous renal replacement therapy and L-carnitine supplementation. Cureus. 2021, 13:e15968. 10.7759\/cureus.15968","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/122431-valproate-induced-encephalopathy-presenting-at-therapeutic-blood-concentrations-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:04Z","timestamp":1707508444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/122431-valproate-induced-encephalopathy-presenting-at-therapeutic-blood-concentrations-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.33559","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,9]]}}}